Related Experiment Videos
Coagulation factor Xa: the prothrombinase complex as an emerging therapeutic target for small molecule inhibitors
1Medicinal Chemistry Research, COR Therapeutics Inc., South San Francisco, CA 94080, USA. rscarborough@corr.com
Journal of Enzyme Inhibition
|October 16, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Discovery of transition state factor Xa inhibitors as potential anticoagulant agents.
Current topics in medicinal chemistry·2002
Design, synthesis, and SAR of amino acid derivatives as factor Xa inhibitors.
Bioorganic & medicinal chemistry letters·2001
Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors.
Bioorganic & medicinal chemistry letters·2001
Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12)).
Bioorganic & medicinal chemistry letters·2001
Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 2: design of potent antagonists containing the 3-azaspiro[5.5]undecanes.
Bioorganic & medicinal chemistry letters·2001
Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 1: design of potent and specific 3,9-diazaspiro[5.5]undecanes.
Bioorganic & medicinal chemistry letters·2001
Lauryl gallate inhibits the activity of protein tyrosine kinase c-Src purified from human platelets.
Journal of enzyme inhibition·2002
An invertase inhibitory protein from Pteris deflexa link fronds.
Journal of enzyme inhibition·2002
Rh-Catalyzed regioselective C7Ar-allylation of tryptophan with VCC and its late-stage peptide diversification.
Chemical communications (Cambridge, England)·2026
Tripeptide-based amyloid hydrogels: phenylalanine mutation outcomes on self-assembly, hydrogelation and their cytotoxicity assays.
Journal of materials chemistry. B·2026